Learn about Ketamine Treatment
Who can benefit from Ketamine?
Klaris Mind treats adults with treatment-resistant depression, anxiety disorders, and PTSD — conditions that have not responded adequately to standard treatments such as medication or psychological therapy.
A comprehensive psychiatric assessment is conducted to determine whether IV ketamine treatment is an appropriate option as part of an individual care plan.
Our clinic provides highly trained consultant-led ketamine treatments in a safe, supportive environment, with care tailored to each patient’s unique needs. Our goal is to help patients regain hope, improve emotional well-being, and move toward meaningful, lasting recovery.
What is Ketamine?
Ketamine is licensed in the UK as an anaesthetic. Its use for depression, anxiety and PTSD is off-label, meaning it is prescribed outside the conditions it was originally licensed for.
This is a recognised and lawful practice in psychiatry, and your Consultant Psychiatrist will discuss what this means for you as part of your assessment.
At low, carefully controlled doses, ketamine acts on different pathways in the brain to many conventional antidepressants, which is why some patients who have not responded to standard treatments are considered for it.
Are there any risks?
Like any medical treatment, IV ketamine can have side effects. The most common are temporary and may include nausea, dizziness, a short-term rise in blood pressure, or changes in perception.
These are closely monitored by our clinical team during and after each infusion, and typically settle within the recovery period.
Ketamine is not suitable for everyone. Your psychiatric assessment will identify whether it is an appropriate and safe option for you individually.
Is Ketamine Safe Over the Long Term?
Research into ketamine for treatment-resistant depression, anxiety and PTSD is active and growing, though it remains a developing area of psychiatric evidence rather than an established first-line treatment.
Because it is used off-label for these conditions, decisions about starting, continuing, or stopping treatment are made individually with your Consultant Psychiatrist, informed by your own response and regularly reviewed alongside standard outcome measures.
